References

Bedenic, B., 1999. [Development of beta-lactam antibiotic resistance in gram-negative bacteria and the impact of resistance on therapy]. Lijec Vjesn, 121: 249-257.
PubMed  |  

Benson, J.M. and M.C. Nahata, 1988. Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination. Drug. Intell. Clin. Pharm., 22: 534-541.
PubMed  |  

Blanco, M., J.E. Blanco, A. Mora, G. Dahbi and M.P. Alonso et al., 2004. Serotypes, virulence genes and intimin types of Shiga toxin (verotoxin)-producing E. coli isolates from cattle in Spain and identification of a new intimin variant gene (eae-xi). J. Clin. Microbiol., 42: 645-651.
PubMed  |  

Bondareva, N.S. and M.M. Levitov, 1980. [Microbiological transformation of cephalosporin C]. Mikrobiologiia, 49: 870-875.
PubMed  |  

Copper, R.D., 1992. The carbacephems: A new beta-lactam antibiotic class. Am. J. Med., 92: 2S-6S.
PubMed  |  

Diggins, F.W., 1999. The true history of the discovery of penicillin, with refutation of the misinformation in the literature. Br. J. Biomed Sci., 56: 83-93.
PubMed  |  

Domenech-Sanchez, A., S. Hernandez-Alles, L. Martinez-Martinez, V.J. Benedi and S. Alberti, 1999. Identification and characterization of a new porin gene of Klebsiella pneumoniae: Its role in beta-lactam antibiotic resistance. J. Bacteriol., 181: 2726-2732.
Direct Link  |  

Drissi, M., Z.B. Ahmed, B. Dehecq, R. Bakour, P. Plesiat and D. Hocquet, 2008. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: First report in Algeria. Med. Mal. Infect., 38: 187-191.
CrossRef  |  PubMed  |  

Fineran, P.C., H. Slater, L. Everson, K. Hughes and G.P. Salmond, 2005. Biosynthesis of tripyrrole and beta-lactam secondary metabolites in Serratia: integration of quorum sensing with multiple new regulatory components in the control of prodigiosin and carbapenem antibiotic production. Mol. Microbiol., 56: 1495-1517.
PubMed  |  

Guthikonda, R.N., L.D. Cama, M. Quesada, M.F. Woods, T.N. Salzmann and B.G. Christensen, 1987. Structure-activity relationships in the 2-arylcarbapenem series: Synthesis of 1-methyl-2-arylcarbapenems. J. Med. Chem., 30: 871-880.
PubMed  |  

Horiuchi, M., M. Kimura, M. Tokumura, N. Hasebe, T. Arai and K. Abe, 2006. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics. Toxicology, 222: 114-124.
CrossRef  |  Direct Link  |  

Imada, A., M. Kondo, K. Okonogi, K. Yukishige and M. Kuno, 1985. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrob Agents Chemother, 27: 821-827.
CrossRef  |  Direct Link  |  

Jin, W.J., Z.M. Zheng, Q.Q. Wang, A.J. Qin, Y.L. Liu and H.X. Shao, 2005. Comparison of partial sequence of avian E.coli strains with Yersinia HPI. J. Yangzhou Univ. (Agric. Life Sci. Edn.,) 26: 5-7.
Direct Link  |  

Munoz, M., C. Marquez, M. Taguas-Casano, J.A. Soult, J.D. Lopez-Castilla and A.M. Alvarez-Silvan, 2003. Resistance to a beta-lactam antibiotic appearing during therapy for enterobacter cloacae sepsis in a child. Med. Pediatr Oncol., 40: 62-63.
CrossRef  |  Direct Link  |  

Neu, H.C., 1981. A review and summary of the pharmacokinetics of cefoperazone: A new extended-spectrum beta-lactam antibiotic. Ther. Drug Monit., 3: 121-128.
Direct Link  |  

Plhackova, K., S. Becka, F. Skrob and P. Kyslik, 2003. Isolation and characterization of a new strain of Achromobacter sp. with beta-lactam antibiotic acylase activity. Applied Microbiol. Biotechnol., 62: 507-516.
CrossRef  |  Direct Link  |  

Quiroga, M., M.T. Lezcano, B. Martin Talavera, M.G. Caceres and M. Vergara, 2009. Beta-lactam resistance in variants of Aeromonas spp. selected in vitro under antibiotic pressure. J. Chemother, 21: 701-702.
PubMed  |  

Sambrook, J., E.F. Fritsch and T. Maniatis, 1996. Molecular Clone: A Laboratory Manual. 2nd Edn., Chinese Science Press, Beijing.

Scaria, J., U. Chandramouli and S.K. Verma, 2005. Antibiotic Resistance Genes Online (ARGO): A Database on vancomycin and beta-lactam resistance genes. Bioinformation, 1: 5-7.
PubMed  |  

Scribner, R.K., B.C. Wedro, A.H. Weber and M.I. Marks, 1982. Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis. Antimicrob Agents Chemother, 21: 678-680.
PubMed  |  

Snepar, R., G. Poporad, J. Romano and M.E. Levison, 1981. In vitro activity, efficacy and pharmacology of moxalactam, a new beta-lactam antibiotic. Antimicrob Agents Chemother, 20: 642-647.
CrossRef  |  Direct Link  |  

Stein, R.A., R.M. Goetz and G.M. Ganea, 2009. Ceftobiprole: A new beta-lactam antibiotic. Int. J. Clin. Pract., 63: 930-943.
CrossRef  |  Direct Link  |  

Weaver, S.S., G.P. Bodey and B.M. LeBlanc, 1979. Thienamycin: New beta-lactam antibiotic with potent broad-spectrum activity. Antimicrob Agents Chemother, 15: 518-521.
CrossRef  |  Direct Link  |